China’s CanSino seeks more vaccine contracts after AstraZenca deal
CanSino begun researching mRNA technology in 2018 and has built a facility in Shanghai that can produce up to 200 million doses a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID vaccines
Top of ANDA approvals list, low on IP index
India's dominance of ANDA approvals juxtaposed with the continued low ranking in the US Chamber of Commerce’s International IP…
BioNTech to invest $43 mn in German facility for mRNA vaccine
The clinical-scale plant has been operational since August 2022 while the commercial-scale one should be ready by end-2023
German expats in China receive first foreign COVID vaccines
China has so far insisted on using only domestically produced vaccines, shunning Western-made vaccines that use newer mRNA…
EU signs joint procurement deal with Spain’s HIPRA for COVID vaccines
The European Union's executive said in a statement that 14 countries are participating in the agreement, under which they can…
SA stands firm in its demand vaccine production waiver amid objection from pharma cos at WTO…
Negotiators from the sponsoring countries have presented text on waivers and flexibilities to the TRIPS Agreement and a draft…
Germany agrees deal with CureVac, GSK for mRNA vaccines until 2029
The five-year contract allows for production of up to 80 million doses at short notice until 2029, CureVac said, adding that those…
Coping and thriving through COVID-19
As 2021 is about to end, a few stakeholders from the pharma industry share some key lessons learnt in the past year
India committed to supplying COVID-19 vaccines to other nations by year end
The country had suspended exports of COVID-19 vaccines in April to focus on inoculating its own population following a sudden…
Modi addresses India on achieving milestone of 100 crore vaccinations
Acceptance that India enjoys in the world as a pharma hub will be further strengthened, Prime Minister Modi said